Posts Tagged ‘cost savings’
Pear Therapeutics raises $80M; finds cost savings of $2,150 per patient with opioid use disorder
Pear Therapeutics raises $80M in push for reimbursement (MedCity News): Pear Therapeutics raised $80 million in funding, which it plans to use as part of a push for coverage of its digital therapeutics. The Boston-based company has three FDA-cleared products, including digital therapeutics for substance use disorder, opioid use disorder, and most recently, insomnia.
Read More